Erin Hrobak

Erin Hrobak is an accomplished professional in the biopharmaceutical industry with extensive experience in market access and strategy. Currently serving as Executive Director of National Accounts at Madrigal Pharmaceuticals since May 2023, Erin has previously held senior leadership roles at Otsuka Pharmaceutical Companies, including Senior Director of Market Access Regional Accounts and Region Director of Market Access East. As the Founder of Pharm to Market, LLC, Erin provided strategic support to biopharmaceutical organizations in achieving business objectives. Erin's career also includes significant positions at AstraZeneca, where responsibilities encompassed leading market access strategies for various therapeutic areas. Erin began a professional journey with PricewaterhouseCoopers as an Auditor after earning a degree in Accounting from the University of Scranton.